Clinical Trials Browser

Phase 3 × Recruiting × Aromatase Inhibitors × Clear all

NCT07400523 2026-04-17

Ribociclib in Hormone Receptor-positive, HER2-negative Early Breast Cancer With Residual Disease After Neoadjuvant Chemotherapy

Phase 3 Recruiting

Breast Neoplasms

NCT05879926 2026-04-02

OFSET

Phase 3 Recruiting

Breast Neoplasms

NCT06447623 2024-06-07

Apatinib Combined With cdk4/6i in First-line Treatment for HR+/HER2- SNF4 Subtype Breast Cancer

Phase 3 Recruiting

Advanced Breast Cancer